Search

Author/Creator Demetri, George D

2. C‐Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas. Issue 2 (1st August 2014)

Authors:
Sioletic, Stefano; Czaplinski, Jeffrey; Hu, Lan; Fletcher, Jonathan A; Fletcher, Christopher DM; Wagner, Andrew J; Loda, Massimo; Demetri, George D; Sicinska, Ewa T; Snyder, Eric L
Journal:
Journal of pathology
Issue:
Volume 234:Issue 2(2014)
Page Start:
190
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials. Issue 2 (February 2020)

Authors:
Doebele, Robert C; Drilon, Alexander; Paz-Ares, Luis; Siena, Salvatore; Shaw, Alice T; Farago, Anna F; Blakely, Collin M; Seto, Takashi; Cho, Byung Chul; Tosi, Diego; Besse, Benjamin; Chawla, Sant P; Bazhenova, Lyudmila; Krauss, John C; Chae, Young Kwang; Barve, Minal; Garrido-Laguna, Ignacio; Li...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Issue 10028 (16th April 2016)

Authors:
Schöffski, Patrick; Chawla, Sant; Maki, Robert G; Italiano, Antoine; Gelderblom, Hans; Choy, Edwin; Grignani, Giovanni; Camargo, Veridiana; Bauer, Sebastian; Rha, Sun Young; Blay, Jean-Yves; Hohenberger, Peter; D'Adamo, David; Guo, Matthew; Chmielowski, Bartosz; Le Cesne, Axel; Demetri, George D;...
Journal:
Lancet
Issue:
Volume 387:Issue 10028(2016)
Page Start:
1629
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial. Issue 5 (May 2015)

Authors:
Blay, Jean-Yves; Shen, Lin; Kang, Yoon-Koo; Rutkowski, Piotr; Qin, Shukui; Nosov, Dmitry; Wan, Desen; Trent, Jonathan; Srimuninnimit, Vichien; Pápai, Zsuzsanna; Le Cesne, Axel; Novick, Steven; Taningco, Lilia; Mo, Shuyuan; Green, Steven; Reichardt, Peter; Demetri, George D
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 5 (May 2015)

Authors:
Blay, Jean-Yves; Pápai, Zsuzsanna; Tolcher, Anthony W; Italiano, Antoine; Cupissol, Didier; López-Pousa, Antonio; Chawla, Sant P; Bompas, Emmanuelle; Babovic, Nada; Penel, Nicolas; Isambert, Nicolas; Staddon, Arthur P; Saâda-Bouzid, Esma; Santoro, Armando; Franke, Fabio A; Cohen, Patrick; Le-Guen...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
531
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. Issue 11 (November 2020)

Authors:
Gounder, Mrinal; Schöffski, Patrick; Jones, Robin L; Agulnik, Mark; Cote, Gregory M; Villalobos, Victor M; Attia, Steven; Chugh, Rashmi; Chen, Tom Wei-Wu; Jahan, Thierry; Loggers, Elizabeth T; Gupta, Abha; Italiano, Antoine; Demetri, George D; Ratan, Ravin; Davis, Lara E; Mir, Olivier; Dileo, Pal...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 11(2020)
Page Start:
1423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗